Gyeonggi-do
South Korea
15
2026-01-01
10
2025-07-08
These are the the leading inventors for applications assigned to HANMI PHARM CO., LTD.:
HANMI PHARM CO., LTD. based in Gyeonggi-do, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
NOVEL METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX
#2 | 2025-12-04METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX
#3 | 2024-03-14LIQUID FORMULATION OF PROTEIN AND METHODS OF PREPARING THE SAME
#4 | 2024-01-25HYPOTENSIVE PHARMACEUTICAL COMPOSITION COMPRISING TRIPLE ACTIVATOR HAVING ACTIVITY FOR ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS
#5 | 2023-10-19 ✅ Patent 12,350,315 granted on 2025-07-08METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX
#6 | 2023-08-31 ✅ Patent 12,318,430 granted on 2025-06-03Methods of treating neutorpenia using G-CSF protein complex
#7 | 2022-12-01PHARMACEUTICAL PREPARATION COMPRISING AN AMIDE DERIVATIVE INHIBITING THE GROWTH OF CANCER CELL AND A PHARMACEUTICAL PRODUCT CONTAINING THE SAME
#8 | 2022-01-27 ✅ Patent 12,018,060 granted on 2024-06-25Glucagon derivatives
#9 | 2019-08-08 ✅ Patent 10,946,003 granted on 2021-03-16Formulation having improved pH-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof
#10 | 2018-01-04 ✅ Patent 10,513,550 granted on 2019-12-24Glucagon derivatives
#11 | 2017-11-30 ✅ Patent 9,931,406 granted on 2018-04-03Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
#12 | 2017-10-19 ✅ Patent 10,233,230 granted on 2019-03-19Use of a long acting GLP-1/glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver disease
#13 | 2017-04-13 ✅ Patent 10,253,082 granted on 2019-04-09Long-acting insulin and use thereof
#14 | 2015-12-03 ✅ Patent 9,518,043 granted on 2016-12-13Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yi)prop-2-en-1-one
#15 | 2014-04-24 ✅ Patent 9,731,022 granted on 2017-08-15Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
Also check out HANMI PHARM CO., LTD.'s (Gyeonggi-do, South Korea) applicant profile with 17 patent applications submitted.
102674 ⎘